Here, GOT2 KD maintains glutathione/ROS balance by facilitating glutathione synthesis, thereby activating the PI3K/AKT/mTOR pathway and ultimately promoting HCC progression. This evidence concerns the gene GOT2 and hepatocellular carcinoma.